loadpatents
name:-0.017164945602417
name:-0.016237020492554
name:-0.0013060569763184
Smith; Eric Michael Patent Filings

Smith; Eric Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Smith; Eric Michael.The latest application filed is for "anti-il-6 antibody".

Company Profile
1.14.18
  • Smith; Eric Michael - San Diego CA
  • Smith; Eric Michael - Los Angeles CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-IL-6 Antibody
App 20220048985 - Chen; Yan ;   et al.
2022-02-17
Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
Grant 11,180,549 - Chen , et al. November 23, 2
2021-11-23
Methods of Suppressing Rheumatoid Arthritis Using an Anti-IL-6 Antibody
App 20200115445 - Chen; Yan ;   et al.
2020-04-16
Exercise Devices For Users In Confined Space
App 20180229067 - Smith; Eric Michael
2018-08-16
Methods of Suppressing Rheumatoid Arthritis Using An Anti-IL-6 Antibody
App 20170253651 - Chen; Yan ;   et al.
2017-09-07
Pen-injector device containing anti-IL-6 antibodies
Grant 9,631,016 - Chen , et al. April 25, 2
2017-04-25
Anti-IL-6 Antibodies, Compositions, Methods and Uses
App 20160222104 - Chen; Yan ;   et al.
2016-08-04
Anti-IL-6 antibodies, compositions, methods and uses
Grant 9,340,613 - Chen , et al. May 17, 2
2016-05-17
Anti-IL-6 Antibodies, Compositions, Methods and Uses
App 20140099311 - Chen; Yan ;   et al.
2014-04-10
Anti-IL-6 antibodies
Grant 8,623,362 - Chen , et al. January 7, 2
2014-01-07
Anti-IL-6 Antibodies, Compositions, Methods and Uses
App 20130017208 - Chen; Yan ;   et al.
2013-01-17
Anti-IL-6 antibodies, compositions, methods and uses
Grant RE43,672 - Chan , et al. September 18, 2
2012-09-18
Anti-sclerostin antibodies
Grant 8,257,704 - Korytko , et al. September 4, 2
2012-09-04
Anti-IL-6 antibodies, compositions, methods and uses
Grant 8,226,611 - Chen , et al. July 24, 2
2012-07-24
Anti-IL-6 Antibodies, Compositions, Methods and Uses
App 20120045453 - CHEN; YAN ;   et al.
2012-02-23
Methods of treating conditions using anti-IL-6 antibodies
Grant 8,067,003 - Chen , et al. November 29, 2
2011-11-29
Anti-sclerostin Antibodies
App 20110250205 - KORYTKO; Andrew Ihor ;   et al.
2011-10-13
Methods of treatment comprising administering an anti-sclerostin antibody
Grant 7,988,970 - Korytko , et al. August 2, 2
2011-08-02
Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies
App 20110081355 - CHEN; YAN ;   et al.
2011-04-07
Humanized anti-ghrelin antibodies
Grant 7,901,679 - Marquis , et al. March 8, 2
2011-03-08
Anti-IL-6 antibody nucleic acid molecules and methods
Grant 7,833,755 - Chen , et al. November 16, 2
2010-11-16
Anti-Sclerostin Antibodies
App 20100221263 - Korytko; Andrew Ihor ;   et al.
2010-09-02
Anti-sclerostin antibodies
Grant 7,744,874 - Korytko , et al. June 29, 2
2010-06-29
Anti-IL-6 Antibody Nucleic Acid Molecules and Methods
App 20090239258 - Chen; Yan ;   et al.
2009-09-24
Methods Of Optimizing Antibody Variable Region Binding Affinity
App 20090202986 - Huse; William D. ;   et al.
2009-08-13
Humanized Anti-ghrelin Antibodies
App 20090181018 - Marquis; David Matthew ;   et al.
2009-07-16
Anti-il-6 antibodies, compositions, methods and uses
Grant 7,560,112 - Chen , et al. July 14, 2
2009-07-14
Anti-sclerostin Antibodies
App 20090060924 - Korytko; Andrew Ihor ;   et al.
2009-03-05
Anti-IL-6 antibodies, compositions, methods and uses
App 20060257407 - Chen; Yan ;   et al.
2006-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed